From the Journals

Bedtime soon after meals raises reflux risk in pregnancy


 

FROM THE JOURNAL OF CLINICAL GASTROENTEROLOGY

Behavioral intervention may benefit pregnant women

The study is important because heartburn and regurgitation are common challenges during pregnancy, Ziad F. Gellad, MD, of Duke University, Durham, N.C., said in an interview. “Understanding risk factors for these conditions can be helpful in designing behavioral and pharmaceutical therapeutic interventions.”

Dr. Ziad F. Gellad

The link between short MTBT and increased risk for GERD is well-known, said Dr. Gellad. “Lengthening the time to laying supine after a meal is a common recommendation given to patients with GERD and is included in published GERD guidelines.” Although pregnant woman may have been excluded from trials on which the guidelines and recommendations are based, “it is reasonable to expect that findings would translate to this population that is generally higher risk for reflux,” he noted.

Dr. Gellad was interested to see the dose response between MTBT and reflux, with those patients having both daytime and nighttime short MTBT experiencing reflux more often than those with short MTBT in only one of those time periods (4-7 days vs. 1-3 days).

The key message for clinicians is that, for all individuals, pregnant or not, “avoiding late night meals and short meal-to-bed time is an appropriate behavioral intervention to recommend for patients with troublesome heartburn or regurgitation,” Dr. Gellad emphasized. However, more research is needed in some areas, “implementation studies would be helpful to understand how best to educate patients on behavioral modifications known to decrease reflux symptoms.”

The study received no outside funding. The researchers had no financial conflicts to disclose. Dr. Gellad had no relevant financial disclosures, but serves as a member of the GI & Hepatology News board of editors.

Pages

Recommended Reading

Infliximab weakens COVID-19 antibody response for IBD patients
MDedge Internal Medicine
AI system beats endoscopists for detecting early neoplasia in Barrett’s
MDedge Internal Medicine
Treatment paradigm for chronic HBV in flux
MDedge Internal Medicine
Coffee could be the secret weapon against NAFLD
MDedge Internal Medicine
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
MDedge Internal Medicine
Lasting norovirus immunity may depend on T cells
MDedge Internal Medicine
Surveillance endoscopy in Barrett’s may perform better than expected
MDedge Internal Medicine
Low-risk adenomas may not elevate risk of CRC-related death
MDedge Internal Medicine
FDA approves first AI device to detect colon lesions
MDedge Internal Medicine
Verification bias casts doubt on IgA tTG in celiac disease
MDedge Internal Medicine